Ladenburg Thalmann downgrades Cadence Pharmaceuticals (Nasdaq: CADX) from Buy to Neutral.

This article: 59 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE